**Table 3.**

*Analysis of the dynamics of quantitative indicators for the "Dinner" category (Softia S).*


#### **Table 4.**

*indicators "Day 1" and "Day 14."*

*Analysis of the dynamics of quality indicators (Softia S).*

G. On the 1st, 14th, and 28th days of the study, the patients underwent a blood test, determining the level of prealbumin and urea in the blood serum. Furthermore, the patients were examined daily by a speech therapist and a nutritionist. During the daily assessment, the amount of food consumed orally (kcal), the amount of oral nutritional support performed (kcal), the content of proteins, fats, and carbohydrates of the food consumed, the amount of choking during or after drinking, body temperature (number of cases of pyrexia), the presence of dysphonia with phlegm (hoarse/hoarse voice if phlegm is present) are assessed. In addition, we assessed body weight every 2 weeks. The study of the product Softia G included 15 patients, including 8 men and 7 women, with the following distribution:


According to the initial speech therapy evaluation, all patients had a mild degree of dysphagia, making it unnecessary to place a tracheostomy and insert a nasogastric tube for feeding. Moreover, the selected patients, according to the Rosenbek scale (PAS), had an aspiration rating of 2 (food enters the airways, remains above the vocal cords, and clears his throat from the airway), according to the Fiberoptic Endoscopic Dysphagia Severity Scale (FEDSS) scale, all—a penetration rating of 3 (fluid penetration with good protective reflex).

According to the speech therapy examination data, by the end of the study, nine patients showed a complete recovery of the swallowing function, six patients retained residual effects in mild choking (no significant changes were noted outside the use of the product).

During the first 14 days of observation (without *Softia G*), there was no significant increase in food intake. After introducing Softia G into the diet of patients, there was

